The FDA has approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of adults with idiopathic pulmonary ...
Airways dysanapsis, a mismatch between airway calibre and lung volume, has long been observed as a physiological variant ...
That observation encapsulates why chronic disease management as we practise it today is reactive rather than predictive.
Traffic pollution, cabin air quality, and cumulative exposure over years of commuting can have measurable impacts on lung ...
With three-quarters of a century dedicated to advancing cardiovascular science and improving patient care, the ESC ...
Introduction Stroke is the second leading cause of death and disability creating a huge economic burden annually. Robot-assisted training (RT) is a promising therapy in stroke rehabilitation, but for ...
Suspicion for malignancies that are a part of genetic syndromes, such as neurofibromatosis type I (NF-1), should prompt genetic testing ... tumor behind or sacrificing function in order to achieve ...
Real-world use of antifibrotic therapy is associated with greater estimated survival in pulmonary fibrosis interstitial lung disease (PF-ILD).
The complete blood count routine test provides a snapshot of your body's blood production and immunity. The test measures a variety of components in your blood, including red blood cells, white blood ...
The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback